Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Office of the Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol. 2024 Dec;31(13):8721-8722. doi: 10.1245/s10434-024-16146-3. Epub 2024 Sep 16.
Robotic pancreatoduodenectomy is an increasingly accepted alternative for the treatment of pancreatic ductal adenocarcinoma (PDAC). However, the ability to perform a meticulous robotic-assisted superior mesenteric artery (SMA) dissection to obtain a margin-negative resection remains unknown. PDAC within the head of the pancreas (HOP) that involves the superior mesenteric vein (SMV) and portal vein (PV) requires total venous control (TVC) and a 'vein-to-the-right' (or anterior artery-first) approach to SMA dissection to minimize venous congestion and operative blood loss. Here, we demonstrate a robotic pancreatoduodenectomy with TVC and a 'vein-to-the-right' approach.
A 70-year-old woman with cT2N0M0 HOP PDAC with lateral SMV involvement and right gastroepiploic vein occlusion underwent robotic pancreatoduodenectomy after neoadjuvant chemotherapy. After transecting the pancreas, we achieved TVC by dividing the small venous tributaries and encircling the SMV, splenic vein, and PV. We then proceeded with a 'vein-to-the-right' approach. The inferior pancreatoduodenal arteries were divided to minimize HOP inflow and decrease specimen bleeding. Once the specimen was dissected off the periadventitial plane of the distal SMA, the SMV dissection was carefully performed using a partial side-wall vein resection using a vascular stapler.
Total operative time was 7.5 h and estimated blood loss was 25 mL. The patient recovered well postoperatively and was discharged on postoperative day 3. Final pathology exhibited a 2.4 cm, moderately to poorly differentiated adenocarcinoma with negative margins (ypT2N1, 2/38 lymph nodes positive).
For tumors with lateral vein involvement, robotic pancreatoduodenectomy can be safely performed via TVC and a 'vein-to-the-right' approach.
机器人胰十二指肠切除术是治疗胰腺导管腺癌(PDAC)的一种越来越被接受的选择。然而,进行细致的机器人辅助肠系膜上动脉(SMA)解剖以获得阴性切缘的能力尚不清楚。胰头(HOP)内的 PDAC 累及肠系膜上静脉(SMV)和门静脉(PV)需要进行总静脉控制(TVC)和“静脉至右侧”(或前动脉优先)的 SMA 解剖方法,以最大程度地减少静脉充血和手术失血。在这里,我们展示了一种带有 TVC 和“静脉至右侧”方法的机器人胰十二指肠切除术。
一名 70 岁女性患有 cT2N0M0 胰头 PDAC,伴有外侧 SMV 受累和右胃网膜静脉闭塞,在新辅助化疗后接受了机器人胰十二指肠切除术。切断胰腺后,我们通过切断小静脉分支并环绕 SMV、脾静脉和 PV 来实现 TVC。然后我们进行“静脉至右侧”的方法。为了减少胰头的流入并减少标本出血,我们先切断下胰十二指肠动脉。一旦标本从远端 SMA 的外膜平面上解剖下来,就使用血管吻合器小心地进行部分侧壁静脉切除以进行 SMV 解剖。
总手术时间为 7.5 小时,估计失血量为 25 毫升。患者术后恢复良好,术后第 3 天出院。最终病理显示 2.4 厘米的中低分化腺癌,切缘阴性(ypT2N1,2/38 个淋巴结阳性)。
对于有外侧静脉受累的肿瘤,机器人胰十二指肠切除术可以通过 TVC 和“静脉至右侧”的方法安全进行。